(Q44293193)

1 December 2017

Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine (English)

1 reference

1 December 2017

7

Hans-Jürgen Möller

1 reference

1 December 2017

3

Peter Zwanzger

1 reference

1 December 2017

Cornelius Schüle

1

1 reference

1 December 2017

Thomas Baghai

2

1 reference

1 December 2017

Robin Ella

4

1 reference

1 December 2017

Daniela Eser

5

1 reference

1 December 2017

Frank Padberg

6

1 reference

1 December 2017

Rainer Rupprecht

8

1 reference

1 December 2017

28 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

166

1 reference

1 December 2017

3

1 reference

1 December 2017

271-275

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-002-1356-z

1 December 2017

0 references

cites work

The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Quantitative rating of depressive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

The effects of intravenous clomipramine on neurohormones in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Results of the dexamethasone suppression test in psychiatric patients with and without weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Dexamethasone suppression test and REM sleep in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Antiglucocorticoid treatment of depression: double-blind ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

Aging and cortisol resistance to suppression by dexamethasone: a positive correlation

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-002-1356-Z

21 January 2018

12 December 2020

Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects

1 reference

12 December 2020

Serotoninergic Agonists Increase Plasma Levels of β-Endorphin and β-Lipotropin in Humans*

1 reference

12 December 2020

The neuroendocrine effects of oral imipramine

1 reference

12 December 2020

Response to steroid suppression in major depression resistant to antidepressant therapy

1 reference

12 December 2020

Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.

1 reference

12 December 2020

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

1 reference

12 December 2020

Age and the dexamethasone suppression test in depression

1 reference

12 December 2020

Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement

1 reference

12 December 2020

Treatment of major depression with metyrapone and hydrocortisone

1 reference

12 December 2020

Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups

1 reference

12 December 2020

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

1 reference

12 December 2020

The effect of diagnosis and age on the DST: a metaanalytic approach

1 reference

12 December 2020

10.1007/S00213-002-1356-Z

Identifiers

DOI

1 reference

1 December 2017

1 reference